Item 1. FINANCIAL STATEMENTS

BUNGE GLOBAL SA AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(Unaudited)

(U.S. dollars in millions, except per share data)

			Three Months Ended June 30,												Six Months Ended June 30,
			2026						2025						2026						2025
Net sales			$	24,041					$	12,769					$	45,902					$	24,412
Cost of goods sold			(22,360)						(12,031)						(43,455)						(23,077)
Gross profit			1,681						738						2,447						1,335
Selling, general and administrative expenses			(606)						(418)						(1,137)						(798)
Interest income			43						46						88						105
Interest expense			(197)						(106)						(378)						(210)
Foreign exchange gains (losses) – net			(26)						44						(120)						69
Other income (expense) – net			39						187						92						269
Income (loss) from affiliates			9						3						12						8
Income (loss) before income tax			943						494						1,004						778
Income tax (expense) benefit			(236)						(124)						(222)						(204)
Net income (loss)			707						370						782						574
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests			(29)						(16)						(36)						(19)
Net income (loss) attributable to Bunge shareholders (Note 18)			$	678					$	354					$	746					$	555
			0						0
Earnings per share—basic (Note 18)
Net income (loss) attributable to Bunge shareholders - basic			$	3.50					$	2.63					$	3.85					$	4.14
Earnings per share—diluted (Note 18)
Net income (loss) attributable to Bunge shareholders - diluted			$	3.47					$	2.61					$	3.81					$	4.10

The accompanying notes are an integral part of these condensed consolidated financial statements.

BUNGE GLOBAL SA AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(U.S. dollars in millions)

			Three Months Ended June 30,												Six Months Ended June 30,
			2026						2025						2026						2025
Net income (loss)			$	707					$	370					$	782					$	574
Other comprehensive income (loss):
Foreign exchange translation adjustment			(4)						379						60						645
Unrealized gains (losses) on designated hedges, net of tax (expense) benefit of $(3) and $(4) in 2026 and $(1) and $(4) in 2025			(1)						(49)						(16)						(87)
Reclassification of net (gains) losses to net income, net of tax expense (benefit) of $1 and $1 in 2026 and $(1) and $(1) 2025			4						5						16						5
Total other comprehensive income (loss)			(1)						335						60						563
Total comprehensive income (loss)			706						705						842						1,137
Comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests			(25)						(38)						(26)						(54)
Total comprehensive income (loss) attributable to Bunge			$	681					$	667					$	816					$	1,083

The accompanying notes are an integral part of these condensed consolidated financial statements.

BUNGE GLOBAL SA AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(U.S. dollars in millions, except share data)

						June 30, 2026						December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents						$	593					$	1,135
Time deposits under trade structured finance program (Note 3)						45						208
Trade accounts receivable (net of allowances of $161 and $156) (Note 4)						3,931						3,870
Inventories (Note 5)						15,461						13,198
Assets held for sale (Note 2)						312						191
Other current assets (Note 6)						5,873						5,789
Total current assets						26,215						24,391
Property, plant and equipment, net						11,945						11,678
Operating lease assets						1,707						1,686
Goodwill						3,354						3,141
Other intangible assets, net						288						309
Investments in affiliates						1,307						1,495
Deferred income taxes						902						890
Other non-current assets (Note 7)						1,064						938
Total assets						$	46,782					$	44,528
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt (Note 13)						$	4,588					$	3,883
Current portion of long-term debt (Note 13)						1,200						1,337
Letter of credit obligations under trade structured finance program (Note 3)						45						208
Trade accounts payable (includes $874 and $559 carried at fair value) (Note 11)						5,370						4,881
Current operating lease obligations						502						499
Liabilities held for sale (Note 2)						87						61
Other current liabilities (Note 10)						4,942						4,258
Total current liabilities						16,734						15,127
Long-term debt (Note 13)						9,426						8,831
Deferred income taxes						931						988
Non-current operating lease obligations						1,096						1,097
Other non-current liabilities (Note 16)						1,185						1,063
Redeemable noncontrolling interest						68						53
Equity (Note 17):
Registered shares, par value $0.01; authorized not issued – 33,632,445 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2026 – 192,106,786 shares, 2025 – 193,408,656 shares						2						2
Additional paid-in capital						9,838						9,841
Retained earnings						13,339						13,152
Accumulated other comprehensive income (loss) (Note 17)						(6,014)						(6,084)
Treasury shares, at cost; 2026 - 16,404,977 shares and 2025 - 15,103,107 shares						(1,212)						(1,007)
Total Bunge shareholders’ equity						15,953						15,904
Noncontrolling interests						1,389						1,465
Total equity						17,342						17,369
Total liabilities, redeemable noncontrolling interest and equity						$	46,782					$	44,528

The accompanying notes are an integral part of these condensed consolidated financial statements.

BUNGE GLOBAL SA AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(U.S. dollars in millions)

						Six Months Ended June 30,
						2026						2025
OPERATING ACTIVITIES
Net income (loss)						$	782					$	574
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Foreign exchange (gain) loss on net debt						(98)						(208)
Depreciation, depletion and amortization						494						236
Share-based compensation expense						53						35
Deferred income tax expense (benefit)						(20)						20
(Gain) loss on sale of investments and property, plant and equipment						(6)						(148)
Results from affiliates						(19)						(8)
Dividend return on investment						47						29
Other, net						73						58
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
Trade accounts receivable						35						(110)
Inventories						(2,235)						(1,261)
Secured advances to suppliers						(257)						(254)
Trade accounts payable and accrued liabilities						344						(55)
Advances on sales						(201)						(107)
Net unrealized (gains) losses on derivative contracts						93						(120)
Margin deposits						(155)						(59)
Recoverable and income taxes, net						87						71
Marketable securities						(1)						16
Other, net						(142)						(66)
Cash provided by (used for) operating activities						(1,126)						(1,357)
INVESTING ACTIVITIES
Payments made for capital expenditures						(779)						(716)
Acquisitions of businesses (net of cash acquired)						(105)						—
Proceeds from investments						1,275						850
Payments for investments						(654)						(783)
Settlements of net investment hedges						(8)						(27)
Proceeds from disposal of business and property, plant and equipment						14						472
Proceeds from sale of investments in affiliates						—						100
Payments for investments in affiliates						(49)						(63)
Other, net						31						65
Cash provided by (used for) investing activities						(275)						(102)
FINANCING ACTIVITIES
Net change in short-term debt with maturities of three months or less						702						2,704
Proceeds from short-term debt with maturities greater than three months						1,292						670
Repayments of short-term debt with maturities greater than three months						(1,291)						(710)
Proceeds from long-term debt						1,198						2,303
Repayments of long-term debt						(628)						(57)
Repurchases of registered shares						(249)						—
Dividends paid to registered shareholders						(275)						(185)
Capital contributions from (Return of capital to) noncontrolling interest						16						30
Sale of redeemable noncontrolling interest						80						206
Acquisition of noncontrolling interest						—						(18)
Other, net						(13)						(5)
Cash provided by (used for) financing activities						832						4,938
Effect of exchange rate changes on cash and cash equivalents, and restricted cash						(1)						5
Net increase (decrease) in cash and cash equivalents, and restricted cash						(570)						3,484
Cash and cash equivalents, and restricted cash - beginning of period						1,166						3,328
Cash and cash equivalents, and restricted cash - end of period						$	596					$	6,812

The accompanying notes are an integral part of these condensed consolidated financial statements.

BUNGE GLOBAL SA AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS

(Unaudited)

(U.S. dollars in millions, except share data)

																					Registered Shares												Treasury Shares
						Redeemable Non- Controlling Interests																											Shares						Amount						Shares						Amount						Additional Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Non- Controlling Interests						Total Equity
Balance, April 1, 2026						$	51																										194,015,131						$	2					14,496,632						$	(967)					$	9,811					$	13,216					$	(6,017)					$	1,381					$	17,426
Net income (loss)						17																											—						—						—						—						—						678						—						12						690
Other comprehensive income (loss)						(1)																											—						—						—						—						—						—						3						(3)						—
Dividends on registered shares, $2.88 per share						—																											—						—						—						—						—						(555)						—						—						(555)
Dividends to noncontrolling interests on subsidiary common stock						—																											—						—						—						—						—						—						—						(1)						(1)
Capital contribution (return) from (to) noncontrolling interest						1																											—						—						—						—						(1)						—						—						—						(1)
Share-based compensation expense						—																											—						—						—						—						30						—						—						—						30
Repurchase of registered shares						—																											(1,966,107)						—						1,966,107						(249)						—						—						—						—						(249)
Issuance of registered shares, including stock dividends						—																											57,762						—						(57,762)						4						(2)						—						—						—						2
Balance, June 30, 2026						$	68																										192,106,786						$	2					16,404,977						$	(1,212)					$	9,838					$	13,339					$	(6,014)					$	1,389					$	17,342

																					Registered Shares												Treasury Shares
						Redeemable Non- Controlling Interests																											Shares						Amount						Shares						Amount						Additional Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Non- Controlling Interests						Total Equity
Balance, April 1, 2025						$	49																										134,396,552						$	1					20,885,990						$	(1,511)					$	5,490					$	13,034					$	(6,436)					$	966					$	11,544
Net income (loss)						8																											—						—						—						—						—						354						—						8						362
Other comprehensive income (loss)						4																											—						—						—						—						—						—						313						18						331
Dividends on registered shares, $2.80 per share						—																											—						—						—						—						—						(377)						—						—						(377)
Dividends to noncontrolling interests on subsidiary common stock						—																											—						—						—						—						—						—						—						(3)						(3)
Capital contribution (return) from (to) noncontrolling interest						—																											—						—						—						—						—						—						—						23						23
Share-based compensation expense						—																											—						—						—						—						16						—						—						—						16
Issuance of registered shares, including stock dividends						—																											38,200						—						(38,200)						3						(4)						—						—						—						(1)
Balance, June 30, 2025						$	61																										134,434,752						$	1					20,847,790						$	(1,508)					$	5,502					$	13,011					$	(6,123)					$	1,012					$	11,895

The accompanying notes are an integral part of these condensed consolidated financial statements.

BUNGE GLOBAL SA AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS

(Unaudited)

(U.S. dollars in millions, except share data)

																					Registered Shares												Treasury Shares
						Redeemable Non- Controlling Interests																											Shares						Amount						Shares						Amount						Additional Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Non- Controlling Interests						Total Equity
Balance, January 1, 2026						$	53																										193,408,656						$	2					15,103,107						$	(1,007)					$	9,841					$	13,152					$	(6,084)					$	1,465					$	17,369
Net income (loss)						16																											—						—						—						—						—						746						—						20						766
Other comprehensive income (loss)						(2)																											—						—						—						—						—						—						70						(8)						62
Dividends on registered shares, $2.88 per share						—																											—						—						—						—						—						(555)						—						—						(555)
Dividends to noncontrolling interests on subsidiary common stock						—																											—						—						—						—						—						—						—						(4)						(4)
Capital contribution (return) from (to) noncontrolling interest						1																											—						—						—						—						(2)						—						—						17						15
Measurement period adjustment (Note 2)						—																											—						—						—						—						—						—						—						(101)						(101)
Share-based compensation expense						—																											—						—						—						—						53						—						—						—						53
Repurchase of registered shares						—																											(1,966,107)						—						1,966,107						(249)						—						—						—						—						(249)
Issuance of registered shares, including stock dividends						—																											664,237						—						(664,237)						44						(54)						(4)						—						—						(14)
Balance, June 30, 2026						$	68																										192,106,786						$	2					16,404,977						$	(1,212)					$	9,838					$	13,339					$	(6,014)					$	1,389					$	17,342

																					Registered Shares												Treasury Shares
						Redeemable Non- Controlling Interests																											Shares						Amount						Shares						Amount						Additional Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Non- Controlling Interests						Total Equity
Balance, January 1, 2025						$	4																										133,964,235						$	1					21,318,307						$	(1,549)					$	5,325					$	12,838					$	(6,702)					$	1,032					$	10,945
Net income (loss)						7																											—						—						—						—						—						555						—						12						567
Other comprehensive income (loss)						4																											—						—						—						—						—						—						528						31						559
Dividends on registered shares, $2.80 per share						—																											—						—						—						—						—						(377)						—						—						(377)
Dividends to noncontrolling interests on subsidiary common stock						—																											—						—						—						—						—						—						—						(4)						(4)
Capital contribution (return) from (to) noncontrolling interest						—																											—						—						—						—						—						—						—						30						30
Sale of redeemable noncontrolling interest (Note 2)						46																											—						—						—						—						189						—						51						—						240
Acquisition of noncontrolling interest						—																											—						—						—						—						4						—						—						(89)						(85)
Share-based compensation expense						—																											—						—						—						—						35						—						—						—						35
Issuance of registered shares, including stock dividends						—																											470,517						—						(470,517)						41						(51)						(5)						—						—						(15)
Balance, June 30, 2025						$	61																										134,434,752						$	1					20,847,790						$	(1,508)					$	5,502					$	13,011					$	(6,123)					$	1,012					$	11,895

The accompanying notes are an integral part of these condensed consolidated financial statements.

BUNGE GLOBAL SA AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Global SA ("Bunge" or the "Company"), its subsidiaries and variable interest entities ("VIEs") in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues, and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended ("Exchange Act"). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission ("SEC") rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 2025 has been derived from Bunge’s audited consolidated financial statements at that date. Operating results for the six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2025, forming part of Bunge’s 2025 Annual Report on Form 10-K filed with the SEC on February 19, 2026.

On July 2, 2025, Bunge completed its previously announced acquisition ("Acquisition") of Viterra Limited ("Viterra"). See Note 2 - Acquisitions and Dispositions for further details. The condensed consolidated statements of income include results attributable to Viterra from the date of the Acquisition. Therefore, results attributable to Viterra are not included in the condensed consolidated statements of income for the three and six months ended June 30, 2025.

Effective in the third quarter of 2025, the Company changed its segment reporting to align with its new value chain operational structure as a result of the Viterra Acquisition. Corresponding prior period amounts have been recast to conform to current period presentation. Further, during the first quarter of 2026, the Other Oilseeds Processing and Refining segment was renamed to Tropical Oils and Specialty Ingredients. The segment name change had no impact on the composition of the Company’s existing four reportable segments, nor to the Company’s previously reported segment results or the consolidated financial statements. See Note 19 - Segment Information for further details.

Cash, Cash Equivalents, and Restricted Cash

Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the condensed consolidated statements of cash flows. The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the condensed consolidated balance sheets, which sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows.

(US$ in millions)			June 30, 2026						June 30, 2025
Cash and cash equivalents			$	593					$	6,790
Restricted cash included in Other current assets			3						22
Total			$	596					$	6,812

Cash paid for income taxes, net of refunds received, was $90 million and $105 million for the six months ended June 30, 2026, and 2025, respectively. Cash paid for interest expense was $365 million and $203 million for the six months ended June 30, 2026, and 2025, respectively.

New Accounting Pronouncements and Disclosure Rules

In May 2026, the FASB issued ASU 2026-02, Environmental Credits and Environmental Credit Obligations (Topic 818) ("ASU 2026-02"), which provides specific authoritative guidance for recognition, measurement, presentation, and disclosure of environmental credits and environmental credit obligations. ASU 2026-02 is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Entities must adopt the standard using a modified retrospective transition method and early adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832) ("ASU 2025-10"), which provides specific authoritative guidance for recognition, measurement, and presentation of government grants. Either a modified prospective or retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. ASU 2025-10 is effective for annual reporting periods beginning after December 15, 2028, including interim reporting periods within those annual reporting periods. Early adoption is permitted in both periods in which financial statements have not yet been issued or made available for issuance. The adoption of this standard is not expected to have a material impact on Bunge’s consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) ("ASU 2024-03"). The standard is intended to enhance transparency of income statement disclosures, primarily through additional disaggregation of relevant expense captions. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim reporting periods within fiscal years beginning after December 15, 2027. Entities can adopt the change prospectively or retrospectively to any or all prior periods presented in the financial statements. The adoption of this standard will result in expanded disclosure in the Company’s footnotes, but it is not expected to have an impact on the Company’s consolidated financial position or results of operations.

2. ACQUISITIONS AND DISPOSITIONS

Acquisitions

Viterra Limited Business Combination Agreement

On July 2, 2025, Bunge completed its previously announced Acquisition of Viterra in a stock and cash transaction pursuant to a definitive business combination agreement (the "Business Combination Agreement") with Viterra and its shareholders including certain affiliates of Glencore PLC, Canada Pension Plan Investment Board, and British Columbia Investment Management Corporation (collectively, the "Sellers"). The Acquisition of Viterra creates a premier global agribusiness solutions company for food, feed and fuel, well positioned to meet the demands of increasingly complex markets and better serve farmers and end-customers.

Pursuant to the terms of the Business Combination Agreement, Viterra shareholders received approximately 65.6 million registered shares of Bunge, with an aggregate value of approximately $5.3 billion as of July 2, 2025, and approximately $1.9 billion in cash, in return for 100% of the outstanding equity of Viterra. The cash consideration was financed through a combination of cash on hand and Bunge's existing debt instruments.

Upon the closing of the Acquisition, the Sellers owned approximately 33% of Bunge's registered shares.

The following table summarizes the total purchase consideration transferred in exchange for 100% of the outstanding equity and repayment of certain debt of Viterra:

(US$ in millions)
Fair value of Bunge stock issued (1)			$	5,340
Cash consideration (2)			1,880
Repayment of certain debt of Viterra			3,554
Effective settlement of pre-existing relationships			(157)
Total purchase consideration			$	10,617

(1) Based on Bunge's closing share price on the New York Stock Exchange as of July 2, 2025 of $81.39 per share.

(2) Represents the base amount of cash consideration transferred to the Sellers, adjusted for certain items per the terms of the Business Combination Agreement.

Fair Values of Assets Acquired and Liabilities Assumed

The Acquisition of Viterra is accounted for as a business combination using the acquisition method of accounting. Bunge finalized the valuation of the assets acquired and liabilities assumed during the second quarter of 2026. Measurement period adjustments were recorded in the period determined, as if they had been completed at the Acquisition date. During the measurement period, Bunge recorded adjustments resulting in an increase to goodwill of $574 million, primarily related to the valuations of Property, plant and equipment and Investments in affiliates. The measurement period adjustments did not have a material impact on Bunge's condensed consolidated statements of income. The following table summarizes the final allocation of the fair value of assets acquired and liabilities assumed as of the Acquisition date, as included in Bunge's condensed consolidated balance sheet.

(US$ in millions)						July 2, 2025
Cash and cash equivalents						$	1,143
Time deposits under trade structured finance program						481
Trade accounts receivable						1,301
Inventories						5,720
Assets held for sale						688
Other current assets						2,575
Property, plant and equipment						5,025
Operating lease assets						781
Other intangible assets (1)						24
Investments in affiliates						378
Deferred income taxes						191
Other non-current assets						256
Total assets acquired						18,563
Liabilities
Short-term debt						1,131
Current portion of long-term debt (2)						1,231
Letter of credit obligations under trade structured finance program						481
Trade accounts payable						1,520
Current operating lease obligations						248
Liabilities held for sale						227
Other current liabilities						2,050
Long-term debt (2)						2,206
Deferred income taxes						622
Non-current operating lease obligations						482
Other non-current liabilities						288
Net assets acquired						8,077
Less: Noncontrolling interests						(340)
Goodwill (3)						2,880
Fair value of consideration transferred						$	10,617

(1) Other intangible assets primarily consists of a trademark with a useful life of one year.

(2) Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Viterra's aggregate principal of $1.95 billion notes and 1.2 billion Euro notes assumed in the Acquisition was $3.3 billion. The $97 million discount to par value will accrete to interest expense over the remaining term of the notes.

(3) Goodwill was assigned to reportable segments as follows, $1,156 million to Softseed Processing and Refining, $896 million to Soybean Processing and Refining, and $828 million to Grain Merchandising and Milling. The

goodwill is primarily attributable to expected synergies and the assembled workforce of Viterra. None of the goodwill is expected to be deductible for income tax purposes. Goodwill is not amortized to earnings but instead will be reviewed at least annually for impairment.

International Flavors and Fragrances Purchase Agreement

On August 5, 2025, Bunge entered into an asset purchase agreement with Solae, L.L.C. to acquire substantially all assets related to the lecithin, soy protein concentrate and crush businesses of International Flavors and Fragrances, Inc. ("IFF"). On March 1, 2026, the acquisition closed in accordance with the terms of the agreement in exchange for total cash consideration of $105 million, subject to the finalization of certain acquisition closing adjustments.

The acquisition of these certain businesses of IFF is accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at their acquisition date fair value. The valuation of the assets acquired and liabilities assumed has not yet been finalized, and as a result, preliminary estimates have been recorded and are subject to change. Any necessary adjustments from Bunge's preliminary estimates will be finalized within one year from the date of the acquisition completion. Measurement period adjustments will be recorded in the period determined, as if it had been completed at the acquisition date. The following table summarizes the preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date, as included in Bunge's condensed consolidated balance sheet. Net assets acquired were primarily recorded in the Tropical Oils and Specialty Ingredients and Soybean Processing and Refining segments.

(US$ in millions)			March 1, 2026
Trade accounts receivable			$	24
Inventories			48
Other current assets			9
Property, plant and equipment, net			60
Intangibles			8
Total assets acquired			149
Liabilities
Trade accounts payable and accrued liabilities			39
Other current liabilities			6
Net assets acquired			104
Goodwill			1
Fair value of consideration transferred			$	105

Dispositions

European Margarines and Spreads Business Disposition

On March 21, 2025, Bunge entered into an agreement to sell its European margarines and spreads business to Vandemoortele Lipids NV for cash proceeds of approximately $239 million, subject to certain closing adjustments. Completion of the sale is subject to customary closing conditions, including regulatory approval, and it is anticipated to close in 2026.

The following table presents the disposal group's major classes of assets and liabilities included in Assets held for sale and Liabilities held for sale, respectively, on the condensed consolidated balance sheet as of June 30, 2026. Intercompany balances between the disposal group and other Bunge consolidated entities have been omitted. Assets held for sale comprise $200 million and $2 million under the Tropical Oils and Specialty Ingredients segment and Corporate and Other, respectively. Liabilities held for sale comprise $60 million and $2 million under the Tropical Oils and Specialty Ingredients segment and Corporate and Other, respectively.

(US$ in millions)			June 30, 2026
Trade accounts receivable			$	41
Inventories			38
Other current assets			18
Property, plant and equipment, net			89
Operating lease assets			2
Goodwill & Other intangible assets, net			12
Other non-current assets			2
Total assets held for sale			$	202
Trade accounts payable and accrued liabilities			$	49
Other current liabilities			1
Deferred income taxes			1
Other non-current liabilities			11
Total liabilities held for sale			$	62

Partnership with Repsol - Bunge Iberica SA

On March 26, 2024, Bunge entered into a definitive stock purchase agreement with Repsol Industrial Transformation, SLU, a wholly owned subsidiary of Repsol SA ("Repsol"), whereby Bunge agreed to divest 40% of its Spanish operating subsidiary, Bunge Iberica SA ("BISA"). BISA operates three industrial facilities in the Iberian Peninsula. On March 4, 2025, the transaction closed in accordance with the terms of the definitive stock purchase agreement for a total net amount of approximately $206 million in cash and $80 million in deferred consideration. Following transaction close, Bunge retains a controlling financial interest in BISA and continues to consolidate the entity. On April 1, 2026, Bunge collected $80 million in deferred consideration, which is recognized as a financing cash inflow within Sale of redeemable noncontrolling interest in the condensed consolidated statement of cash flows.

3. TRADE STRUCTURED FINANCE PROGRAM

The Company engages in various trade structured finance activities to leverage the value of its global trade flows. These activities include programs under which the Company generally obtains U.S. dollar and foreign currency denominated letters of credit ("LCs") from financial institutions, each based on an underlying commodity trade flow, and time deposits denominated in U.S. dollars and foreign currencies, as well as foreign exchange forward contracts, in which trade related payables are set-off against receivables, all of which are subject to legally enforceable set-off agreements.

As of June 30, 2026, and December 31, 2025, time deposits and LCs of $13,134 million and $10,437 million, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting, had been met. Time deposits and LCs that do not meet the offsetting requirements under ASC 210-20 are reported on the condensed consolidated balance sheet within Time deposits under trade structured finance program and Letter of credit obligations under trade structured finance program, respectively. The carrying amounts of these financial instruments approximate their fair values. At June 30, 2026, and December 31, 2025, time deposits, including those presented on a net basis, carried weighted-average interest rates of 2.97% and 3.56%, respectively.

As part of the trade structured finance activities, the LCs originated using the time deposits described above may be sold to financial institutions on a discounted basis. When the criteria in ASC 860, Transfers and Servicing, have been met, Bunge derecognizes the asset from our balance sheet and does not service the asset. For LCs that do not meet the derecognition criteria, Bunge accounts for such transactions as secured borrowings within Other short-term debt. During the six months ended June 30, 2026, and 2025, total net proceeds from discounting of LCs were $7,098 million and $4,291 million, respectively. These cash inflows were offset by the related cash outflows resulting from placement of the time deposits and repayment of the

LCs. All cash flows related to the programs are included in operating activities in the condensed consolidated statements of cash flows.

The terms of the sale may require the Company to continue to make periodic interest payments to financial institutions based on changes in the Secured Overnight Financing Rate ("SOFR") for a period of up to one year. Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current assets, or Other current liabilities, including any unrealized gain or loss on changes in SOFR, is not significant as of June 30, 2026 or December 31, 2025. The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company’s condensed consolidated balance sheets as of June 30, 2026, and December 31, 2025 are included in Note 12 - Derivative Instruments and Hedging Activities. The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the three and six month periods ended June 30, 2026, and 2025.

4. TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM

Trade Accounts Receivable

Changes to the allowance for expected credit losses related to Trade accounts receivable were as follows:

			Six Months Ended June 30, 2026
Rollforward of the Allowance for Credit Losses (US$ in millions)			Short-term			Long-term (1)			Total
Allowance as of January 1, 2026			$	156		$	41		$	197
Current period provisions			50			2			52
Recoveries			(33)			(1)			(34)
Write-offs charged against the allowance			(16)			(9)			(25)
Foreign exchange translation differences			4			1			5
Allowance as of June 30, 2026			$	161		$	34		$	195

(1) Long-term portion of the allowance for credit losses is included in Other non-current assets.

			Six Months Ended June 30, 2025
Rollforward of the Allowance for Credit Losses (US$ in millions)			Short-term			Long-term (1)			Total
Allowance as of January 1, 2025			$	89		$	24		$	113
Current period provisions			19			—			19
Recoveries			(20)			—			(20)
Write-offs charged against the allowance			(13)			—			(13)
Foreign exchange translation differences			3			1			4
Allowance as of June 30, 2025			$	78		$	25		$	103

(1) Long-term portion of the allowance for credit losses is included in Other non-current assets.

Trade Receivables Securitization Program

Bunge and certain of its subsidiaries participate in a trade receivables securitization program (the "Program") with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers (collectively, the "Purchasers"). Koninklijke Bunge B.V., a wholly owned subsidiary of Bunge, acts as master servicer, responsible for servicing and collecting the accounts receivable for the Program. The Program is designed to enhance Bunge’s financial flexibility by providing an additional source of liquidity for its operations.

On March 31, 2026, Bunge and certain of its subsidiaries amended the Program which increased its aggregate size by $500 million to an aggregate of $2.0 billion. The amendment also decreased the size of the accordion feature under the Program, which allows Bunge to request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments, by $500 million reducing from $1.0 billion to $500 million. The Program will terminate on May 17, 2031; however, each committed purchaser's commitment to purchase trade receivables under the Program will terminate earlier on December 16, 2026, with a feature that permits Bunge to request 364-day extensions.

Under the Program's pledge structure, Bunge Securitization B.V. ("BSBV"), a consolidated bankruptcy remote special purpose entity, transfers certain trade receivables to the Purchasers in exchange for a cash payment up to the aggregate size of the Program. BSBV also retains ownership of a population of unsold receivables. BSBV agrees to guarantee the collection of sold receivables and grants a lien to the administrative agent on all unsold receivables. Collections on unsold receivables and guarantee payments are classified as operating activities in Bunge’s condensed consolidated statements of cash flows.

(US$ in millions)			June 30, 2026						December 31, 2025
Receivables sold which were derecognized from Bunge's balance sheet			$	1,650					$	1,174
Receivables pledged to the administrative agent and included in Trade accounts receivable			$	299					$	182

Bunge's risk of loss following the sale of trade receivables is limited to the assets of BSBV, primarily comprised of unsold receivables pledged to the administrative agent.

The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated with the Program. Servicing fees under the Program were not significant in any period.

			Six Months Ended June 30,
(US$ in millions)			2026						2025
Gross receivables sold			$	8,652					$	6,166
Proceeds received in cash related to transfers of receivables			$	8,626					$	6,141
Cash collections from customers on receivables previously sold			$	8,176					$	6,214
Discounts related to gross receivables sold included in Selling, general, and administrative expenses			$	26					$	25

5. INVENTORIES

Inventories by reportable segment consist of the following:

(US$ in millions)			June 30, 2026						December 31, 2025
Soybean Processing and Refining			$	8,389					$	5,378
Softseed Processing and Refining			2,698						2,663
Tropical Oils and Specialty Ingredients			996						924
Grain Merchandising and Milling			3,378						4,233
Total			$	15,461					$	13,198

Readily marketable inventories ("RMI") are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, corn, softseeds, softseed oil, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms. All other inventories are carried at lower of cost or net realizable value.

RMI by reportable segment consist of the following, reported within Inventories:

(US$ in millions)			June 30, 2026						December 31, 2025
Soybean Processing and Refining (1)			$	7,671					$	4,772
Softseed Processing and Refining			2,219						2,371
Tropical Oils and Specialty Ingredients			357						306
Grain Merchandising and Milling			3,064						3,912
Total			$	13,311					$	11,361

(1) Assets held for sale also includes RMI of $65 million and zero at June 30, 2026 and December 31, 2025, respectively.

6. OTHER CURRENT ASSETS

Other current assets consist of the following:

(US$ in millions)			June 30, 2026						December 31, 2025
Unrealized gains on derivative contracts, at fair value			$	1,904					$	1,534
Prepaid commodity purchase contracts (1)			740						284
Secured advances to suppliers, net (2)			283						455
Recoverable taxes, net			586						636
Margin deposits			1,034						850
Marketable securities and other short-term investments (3)			195						861
Income taxes receivable			230						234
Prepaid expenses			429						342
Restricted cash			3						31
Disposition receivable (4)			—						80
Other			469						482
Total			$	5,873					$	5,789

(1) Prepaid commodity purchase contracts represent advance payments against contracts for future deliveries of specified quantities of agricultural commodities. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14 - Related Party Transactions.

(2) Bunge provides cash advances to suppliers, primarily Brazilian soybean farmers, to finance a portion of the suppliers’ production costs. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14 - Related Party Transactions. The Company does not bear any of the costs or operational risks associated with growing the related crops. The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmers' crops are harvested and sold. The secured advances to suppliers are reported net of allowances of $5 million and $20 million at June 30, 2026, and December 31, 2025, respectively.

(-) Interest earned on secured advances to suppliers of $7 million and $5 million for the three months ended June 30, 2026, and 2025, respectively, and $18 million and $10 million for the six months ended June 30, 2026, and 2025, respectively, is included in Net sales in the condensed consolidated statements of income.

(3) Marketable securities and other short-term investments - Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded in the Company’s condensed consolidated balance sheets as marketable securities and other short-term investments.

(US$ in millions)			June 30, 2026						December 31, 2025
Foreign government securities			$	126					$	146
Certificates of deposit/time deposits			4						503
Equity securities			—						4
Other			65						208
Total			$	195					$	861

As of June 30, 2026, and December 31, 2025, $126 million and $150 million, respectively, of marketable securities and other short-term investments were recorded at fair value. All other investments were recorded at cost, and due to the short-term nature of these investments, their carrying values approximate fair values. For the three months ended June 30, 2026, and 2025, unrealized gains of $3 million and $9 million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at June 30, 2026, and 2025. For the six months ended June 30, 2026, and 2025, unrealized loss of $5 million and $8 million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at June 30, 2026, and 2025.

(4) On March 4, 2025, Bunge completed the sale of 40% of its Spanish operating subsidiary, BISA, to Repsol. In connection with the sale, a disposition receivable of $80 million was recorded at December 31, 2025 and collected on April 1, 2026. See Note 2 - Acquisitions and Dispositions for further information*.*

7. OTHER NON-CURRENT ASSETS

Other non-current assets consist of the following:

(US$ in millions)			June 30, 2026						December 31, 2025
Recoverable taxes, net (1)			$	169					$	143
Judicial deposits (1)			140						103
Other long-term receivables, net (2)			41						16
Income taxes receivable (1)			148						132
Long-term investments (3)			140						136
Affiliate loans receivable			12						12
Long-term receivables from farmers in Brazil, net (1)			109						96
Unrealized gains on derivative contracts, at fair value			1						8
Long-term pension surplus			147						148
Other			157						144
Total			$	1,064					$	938

(1) A significant portion of these non-current assets arise from the Company’s Brazilian and Canadian operations and their realization could take several years.

(2) Net of allowances as described in Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program.

(3) As of June 30, 2026, and December 31, 2025, $26 million and $28 million, respectively, of long-term investments are recorded at fair value.

Recoverable taxes, net - Recoverable taxes include value-added taxes paid upon the acquisition of property, plant and equipment, raw materials and taxable services, and other transactional taxes which can be recovered in cash or as compensation against income taxes, or other taxes Bunge may owe, primarily in Brazil. Recoverable taxes are reported net of allowances of $5 million and $6 million at June 30, 2026, and December 31, 2025, respectively.

Judicial deposits - Judicial deposits are funds the Company has placed on deposit with the courts in Brazil. These funds are held in judicial escrow relating to certain legal proceedings pending resolution and bear interest at the Selic rate, which is the benchmark rate of the Brazilian central bank.

Income taxes receivable - Income taxes receivable includes overpayments of current income taxes plus accrued interest. These income tax prepayments are expected to be used for the settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the Selic rate.

Long-term investments - Long-term investments primarily comprise Bunge's noncontrolling equity investments held by Bunge Ventures in growth stage companies and related investment funds in the agribusiness and food sectors.

Affiliate loans receivable - Affiliate loans receivable are primarily interest-bearing receivables from unconsolidated affiliates with remaining maturities of greater than one year.

Long-term receivables from farmers in Brazil, net - The Company provides financing to farmers in Brazil, primarily through secured advances against farmer commitments to deliver agricultural commodities (primarily soybeans) upon harvest, and through credit sales of fertilizer to farmers. The balance includes certain advance payments on contracts with various unconsolidated investees (see Note 14 - Related Party Transactions). Long-term receivables from farmers are originally recorded in Other current assets as prepaid commodity purchase contracts or secured advances to suppliers (see Note 6 - Other Current Assets) or Other non-current assets according to their maturity. Advances initially recorded in Other current assets are reclassified to Other non-current assets if collection issues arise and amounts become past due with resolution of such matters expected to take more than one year. The balance is reported net of allowances of $33 million and $31 million at June 30, 2026 and December 31, 2025, respectively.

8. VARIABLE INTEREST ENTITIES

Consolidated Variable Interest Entities

Bunge Chevron Ag Renewables LLC ("BCAR") is a VIE in which Bunge is considered to be the primary beneficiary because it is responsible for the day-to-day operating decisions of BCAR as well as the marketing of the principal products, primarily soybean meal and oil produced and sold by BCAR, among other factors.

The following table presents the values of the assets and liabilities associated with BCAR to the extent included in Bunge’s condensed consolidated balance sheets as of June 30, 2026, and December 31, 2025. All amounts exclude intercompany balances, which have been eliminated upon consolidation.

For all other VIEs in which Bunge is considered the primary beneficiary, the entities meet the definition of a business, and the VIE's assets can be used other than for the settlement of the VIE’s obligations. As such, these VIEs have been excluded from the below table.

(US$ in millions)			June 30, 2026						December 31, 2025
Current assets:
Cash and cash equivalents			$	12					$	226
Trade accounts receivable			—						3
Inventories			111						58
Other current assets			85						37
Total current assets			208						324
Property, plant and equipment, net			900						714
Total assets			$	1,108					$	1,038
Current liabilities:
Trade accounts payable and accrued liabilities			$	78					$	81
Other current liabilities			95						45
Total liabilities			$	173					$	126

Non-Consolidated Variable Interest Entities

For information on VIEs for which Bunge has determined it is not the primary beneficiary, along with the Company’s related maximum exposure to losses associated with such investments, please refer to Note 11 - Investments in Affiliates and Variable Interest Entities, included in the Company’s 2025 Annual Report on Form 10-K filed with the SEC on February 19, 2026.

9. INCOME TAXES

Income tax expense is provided on an interim basis based on management’s estimate of the annual effective income tax rate and includes the tax effects of certain discrete items, such as changes in tax laws or tax rates or other unusual or non-recurring tax adjustments in the interim period in which they occur. In addition, results from jurisdictions projecting a loss for the year where no tax benefit can be recognized are treated discretely in the interim period in which they occur. The effective tax rate is highly dependent on the geographic distribution of the Company’s worldwide earnings or losses and tax regulations in each jurisdiction. Management regularly monitors the assumptions used in estimating its annual effective tax rate, including the realizability of deferred tax assets, and adjusts estimates accordingly. Volatility in earnings within a taxing jurisdiction could result in a determination that additional valuation allowance adjustments may be warranted.

Income tax expense for the three and six months ended June 30, 2026 was $236 million and $222 million, respectively. Income tax expense for the three and six months ended June 30, 2025 was $124 million and $204 million. The effective tax rates for the three and six months ended June 30, 2026 and June 30, 2025 were higher than the U.S. statutory rate of 21%, primarily due to the jurisdictional mix of earnings.

As a global enterprise, the Company files income tax returns that are subject to periodic examination and challenge by federal, state, and foreign tax authorities. In many jurisdictions, income tax examinations, including settlement negotiations or

litigation, may take several years to finalize. The Company is currently under examination or litigation in various locations throughout the world. While it is difficult to predict the outcome or timing of resolution of any particular matter, management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.

10. OTHER CURRENT LIABILITIES

Other current liabilities consist of the following:

(US$ in millions)			June 30, 2026						December 31, 2025
Unrealized losses on derivative contracts at fair value			$	1,880					$	1,408
Accrued liabilities			1,333						1,390
Advances on sales (1)			603						814
Dividends payable (2)			415						135
Income tax payable			145						103
Contingent consideration (3)			20						18
Other			546						390
Total			$	4,942					$	4,258

(1) The Company records advances on sales when cash payments are received in advance of the Company’s performance and recognizes revenue once the related performance obligation is completed. Advances on sales are impacted by the seasonality of Bunge's business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less.

(2) See Note 17 - Equity.

(3) In the fourth quarter of 2025, Bunge completed the acquisition of an oilseed crush facility from Varthomio ("ViOil") in western Ukraine. In connection with the acquisition, Bunge has recognized an obligation of $20 million at June 30, 2026 relating to contingent cash consideration to be settled within one year from the date of the close of the transaction.

11. FAIR VALUE MEASUREMENTS

Bunge's various financial instruments include certain components of working capital such as Trade accounts receivable and Trade accounts payable. Additionally, Bunge uses short- and long-term debt to fund operating requirements. Trade accounts receivable, Trade accounts payable, and Short-term debt are generally stated at their carrying value, which is a reasonable estimate of fair value. See Note 3 - Trade Structured Finance Program for trade structured finance program, Note 7 - Other Non-Current Assets for long-term receivables from farmers in Brazil, net and other long-term investments, and Note 13 - Debt for short- and long-term debt. Bunge's financial instruments also include derivative instruments and marketable securities, which are stated at fair value.

The fair value standard describes three levels within its hierarchy that may be used to measure fair value.

Level			Description			Financial Instrument (Assets / Liabilities)
Level 1			Quoted prices (unadjusted) in active markets for identical assets or liabilities.			Exchange traded derivative contracts. Marketable securities in active markets.
Level 2			Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.			Exchange traded derivative contracts (less liquid markets). Readily marketable inventories. Over-the-counter ("OTC") commodity purchase and sales contracts. OTC derivatives whose value is determined using pricing models with inputs that are generally based on exchange traded prices, adjusted for location specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data. Marketable securities in less active markets.
Level 3			Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities.			Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques. Assets and liabilities for which the determination of fair value requires significant management judgment or estimation.

In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.

For a further definition of fair value and the associated fair value levels, refer to Note 15 - Fair Value Measurements, included in the Company’s 2025 Annual Report on Form 10-K filed with the SEC on February 19, 2026.

The following table sets forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis.

						Fair Value Measurements at Reporting Date
						June 30, 2026															December 31, 2025
(US$ in millions)						Level 1			Level 2			Level 3			Total						Level 1			Level 2			Level 3			Total
Assets:
Cash equivalents						$	—		$	1		$	—		$	1					$	1		$	90		$	—		$	91
Readily marketable inventories(1) (Note 5)						—			10,525			2,851			13,376						—			9,954			1,407			11,361
Unrealized gain on derivative contracts (2):
Interest rate						1			12			—			13						—			13			—			13
Foreign exchange						3			515			—			518						—			327			—			327
Commodities						303			694			204			1,201						179			706			227			1,112
Freight						33			—			—			33						33			—			—			33
Energy						138			—			—			138						56			—			—			56
Credit						—			4			—			4						—			1			—			1
Other (3)						91			61			—			152						117			61			—			178
Total assets						$	569		$	11,812		$	3,055		$	15,436					$	386		$	11,152		$	1,634		$	13,172
Liabilities:
Trade accounts payable (4)						$	—		$	556		$	318		$	874					$	—		$	464		$	95		$	559
Unrealized loss on derivative contracts (5):
Interest rate						1			203			—			204						—			120			—			120
Foreign exchange						3			450			—			453						—			329			—			329
Commodities						267			783			221			1,271						154			581			206			941
Freight						83			—			—			83						53			—			—			53
Energy						93			—			—			93						84			—			—			84
Credit						—			2			—			2						—			1			—			1
Total liabilities						$	447		$	1,994		$	539		$	2,980					$	291		$	1,495		$	301		$	2,087

(1) At June 30, 2026, there were RMI totaling $65 million included in Assets held for sale.

(2) Unrealized gains on derivative contracts are generally included in Other current assets. There were $1 million and $8 million included in Other non-current assets at June 30, 2026, and December 31, 2025, respectively. At June 30, 2026, and December 31, 2025, there were $2 million and zero, respectively, included in Assets held for sale.

(3) Other includes the fair values of marketable securities and investments in Other current assets and Other non-current assets.

(4) These payables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business.

(5) Unrealized losses on derivative contracts are generally included in Other current liabilities. There were $225 million and $120 million included in Other non-current liabilities at June 30, 2026, and December 31, 2025, respectively. At June 30, 2026, and December 31, 2025, there were $1 million and zero, respectively, included in Liabilities held for sale.

Cash equivalents —Cash equivalents primarily includes money market funds and commercial paper investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Cash equivalents with liquid prices are valued using prices from publicly available sources and classified as Level 1. Cash equivalents with less liquid prices are valued using third-party quotes or pricing models and classified as Level 2.

Readily marketable inventories—RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where the Company’s inventories are located. In such cases, the inventory is classified within Level 2. Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3.

If the Company used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ. Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ.

Derivatives—The majority of exchange traded futures and options contracts and exchange cleared contracts are valued based on unadjusted quoted prices in active markets and are classified within Level 1. The majority of the Company’s exchange-traded agricultural commodity futures are cash-settled on a daily basis and, therefore, are not included in these tables. The Company’s forward commodity purchase and sales contracts are classified as derivatives along with other OTC derivative instruments relating primarily to freight, energy, foreign exchange and interest rates, and are classified within Level 2 or Level 3, as described below. The Company estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets. These differences are generally valued using inputs from broker or dealer quotations or market transactions in either the listed or OTC markets. In such cases, these derivative contracts are classified within Level 2.

OTC derivative contracts include swaps, options, and structured transactions that are generally fair valued using quantitative models that require the use of multiple market inputs including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets which are not highly active, other observable inputs relevant to the asset or liability, and market inputs corroborated by correlation or other means. These valuation models include inputs such as interest rates, prices, and indices, to generate continuous yield or pricing curves and volatility factors. Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2. Certain OTC derivatives trade in less active markets with less availability of pricing information and certain structured transactions can require internally developed model inputs that might not be observable in or corroborated by the market.

Marketable securities and investments—Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Marketable securities and investments with liquid prices are valued using prices from publicly available sources and classified as Level 1. Marketable securities and investments with less liquid prices are valued using third-party quotes or pricing models and classified as Level 2 or Level 3, as described below.

Level 3 Measurements

The following relates to assets and liabilities measured at fair value on a recurring basis using Level 3 measurements. An instrument may transfer into or out of Level 3 due to inputs becoming either observable or unobservable.

Level 3 Measurements—Transfers in and/or out of Level 3 represent existing assets or liabilities that were either previously categorized as a higher level for which the inputs to the model became unobservable or assets and liabilities that were previously classified as Level 3 for which the lowest significant input became observable during the period. Bunge's policy regarding the timing of transfers between levels is to record the transfers at the end of the reporting period.

Level 3 Readily marketable inventories and Trade accounts payable—The significant unobservable inputs resulting in Level 3 classification for RMI, physically settled forward purchase and sales contracts, and Trade accounts payable, relate to certain management estimations regarding costs of transportation and other local market or location-related adjustments, primarily freight related adjustments in the interior of Brazil and the lack of market corroborated information in Canada. In both situations, the Company uses proprietary information such as purchase and sales contracts and contracted prices to value freight, premiums and discounts in its contracts. Movements in the prices of these unobservable inputs alone would not be expected to have a material effect on the Company’s financial statements as these contracts do not typically exceed one future crop cycle.

Level 3 Derivatives—Level 3 derivative instrument fair value measurements utilize both market observable and unobservable inputs. These inputs include commodity prices, price volatility, interest rates, volumes, and locations.

Level 3 Others—Primarily relates to marketable securities and investments valued using third-party quotes or pricing models with inputs based on similar securities adjusted to reflect management’s best estimate of the specific characteristics of the securities held by the Company. Such inputs represent a significant component of the fair value of the securities held by the Company, resulting in the securities being classified as Level 3.

The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2026, and 2025. These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant.

			Three Months Ended June 30, 2026
(US$ in millions)			Readily Marketable Inventories			Derivatives, Net			Trade Accounts Payable						Total
Balance, April 1, 2026			$	2,532		$	(3)		$	(336)					$	2,193
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)			352			23			(8)						367
Purchases			2,168			—			(155)						2,013
Sales			(1,955)			—			—						(1,955)
Settlements			—			—			173						173
Transfers into Level 3			1,372			(8)			(2)						1,362
Transfers out of Level 3			(1,631)			(29)			12						(1,648)
Translation adjustment			13			—			(2)						11
Balance, June 30, 2026			$	2,851		$	(17)		$	(318)					$	2,516

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $312 million, $25 million and $(8) million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2026.

			Three Months Ended June 30, 2025
(US$ in millions)			Readily Marketable Inventories			Derivatives, Net			Trade Accounts Payable						Total
Balance, April 1, 2025			$	1,362		$	28		$	(301)					$	1,089
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)			21			(21)			4						4
Purchases			681			—			(125)						556
Sales			(642)			—			—						(642)
Settlements			—			—			163						163
Transfers into Level 3			382			7			(1)						388
Transfers out of Level 3			(329)			—			2						(327)
Translation adjustment			60			1			(15)						46
Balance, June 30, 2025			$	1,535		$	15		$	(273)					$	1,277

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $41 million, $(26) million and $5 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2025.

			Six Months Ended June 30, 2026
(US$ in millions)			Readily Marketable Inventories			Derivatives, Net			Trade Accounts Payable						Total
Balance, January 1, 2026			$	1,407		$	21		$	(95)					$	1,333
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)			912			11			2						925
Purchases			4,454			—			(425)						4,029
Sales			(3,310)			—			—						(3,310)
Settlements			—			—			197						197
Transfers into Level 3			2,114			11			(9)						2,116
Transfers out of Level 3			(2,758)			(56)			18						(2,796)
Translation adjustment			32			(4)			(6)						22
Balance, June 30, 2026			$	2,851		$	(17)		$	(318)					$	2,516

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $910 million, $(68) million and $1 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2026.

			Six Months Ended June 30, 2025
(US$ in millions)			Readily Marketable Inventories			Derivatives, Net			Trade Accounts Payable						Total
Balance, January 1, 2025			$	419		$	30		$	(62)					$	387
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)			95			(27)			12						80
Purchases			1,706			—			(387)						1,319
Sales			(1,216)			—			—						(1,216)
Settlements			—			—			185						185
Transfers into Level 3			947			10			(5)						952
Transfers out of Level 3			(496)			(1)			3						(494)
Translation adjustment			80			3			(19)						64
Balance, June 30, 2025			$	1,535		$	15		$	(273)					$	1,277

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $117 million, $(29) million and $12 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2025.

12. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative instruments to manage several market risks, such as interest rate, foreign currency rate, and commodity risk. Some of the hedges the Company enters into qualify for hedge accounting ("Hedge Accounting Derivatives") and some, while intended as economic hedges, do not qualify or are not designated for hedge accounting ("Economic Hedge Derivatives"). As these derivatives impact the financial statements in different ways, they are discussed separately below.

Hedge Accounting Derivatives - The Company uses derivatives in qualifying hedge accounting relationships to manage certain of its interest rate, foreign currency, and commodity risks. In executing these hedge strategies, the Company primarily relies on the shortcut and critical terms match methods in designing its hedge accounting strategy, which results in little to no net earnings impact for these hedge relationships. The Company monitors these relationships on a quarterly basis and performs a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative.

Fair value hedges - These derivatives are used to hedge the effect of interest rate and currency exchange rate changes on certain long-term debt. Under fair value hedge accounting, the derivative is measured at fair value and the carrying value of hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. In other words, the earnings effect of a change in the fair value of the derivative will be substantially offset by the earnings effect of the change in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense.

Cash flow hedges of currency risk - The Company manages currency risk on certain forecasted purchases, sales, selling, general and administrative costs, and foreign denominated contractual payments using currency forwards and cross-currency swaps. The change in the value of the derivative is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the derivative is reclassified to the condensed consolidated statements of income (loss). These hedges mature at various times through September 2028. Of the amount currently in Accumulated other comprehensive income (loss), less than $2 million of deferred losses, based on transaction maturities, are expected to be reclassified to earnings in the next twelve months.

Net investment hedges - The Company hedges the currency risk of certain of its foreign subsidiaries with currency forwards and foreign currency denominated third-party loans for which the currency risk is remeasured through Accumulated other comprehensive income (loss). For currency forwards, the forward method is used. The change in the value of the hedging instrument is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings by way of either sale or substantial liquidation of the foreign subsidiary.

The table below provides information about the balance sheet values of hedged items and the notional amount of derivatives used in hedging strategies. The notional amount of the derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap). The notional amount is used to compute interest or other payment streams to be made under the contract and is a measure of the Company’s level of activity. The Company discloses derivative notional amounts on a gross basis.

(US$ in millions)						June 30, 2026			December 31, 2025			Unit of Measure
Hedging instrument type:
Fair value hedges of interest rate risk
			Interest rate swap - notional amount			$	7,700		$	6,500		$ Notional
			Cumulative adjustment to long-term debt from active application of hedge accounting			$	(199)		$	(108)		$ Notional
			Carrying value of hedged debt			$	7,426		$	6,321		$ Notional
Cash flow hedges of currency risk
			Foreign currency forward - notional amount			$	70		$	86		$ Notional
			Foreign currency option - notional amount			$	93		$	84		$ Notional
			Cross currency swaps - notional amount			$	588		$	588		$ Notional
			Carrying value of hedged debt under the cross currency swap			$	545		$	556		$ Notional
Net investment hedges
			Foreign currency forward - notional amount			$	56		$	149		$ Notional
			Carrying value of non-derivative hedging instrument			$	235		$	235		$ Notional

Economic Hedge Derivatives - In addition to using derivatives in qualifying hedge relationships, the Company enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations.

Interest rate derivatives are used to hedge exposures to the Company’s financial instrument portfolios and debt issuances. The impact of changes in fair value of these instruments is primarily presented in Interest expense.

Currency derivatives are used to hedge the balance sheet and commercial exposures that arise from the Company’s global operations. The impact of changes in fair value of these instruments is presented in Cost of goods sold when hedging commercial exposures and Foreign exchange (losses) gains – net when hedging monetary exposures.

Agricultural commodity derivatives are used primarily to manage exposures related to the Company’s inventory and forward purchase and sales contracts. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The Company uses derivative instruments referred to as forward freight agreements ("FFAs") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The Company uses energy derivative instruments to manage its exposure to volatility in energy costs. Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives to manage its exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The table below summarizes the volume of economic derivatives as of June 30, 2026, and December 31, 2025. For those contracts traded bilaterally through the over-the-counter markets (e.g., forwards, forward rate agreements ("FRA"), and swaps), the gross position is provided. For exchange traded (e.g., futures, FFAs, and options) and cleared positions (e.g., energy swaps), the net position is provided.

			June 30,						December 31,
			2026						2025						Unit of Measure
(US$ in millions)			Long			(Short)			Long			(Short)
Interest rate
Swaps			$	552		$	(1,395)		$	575		$	(1,421)		$ Notional
Futures			$	—		$	(97)		$	17		$	—		$ Notional
Forwards			$	240		$	(434)		$	248		$	(248)		$ Notional
Currency
Forwards			$	20,747		$	(19,151)		$	17,990		$	(14,387)		$ Notional
Swaps			$	4,897		$	(2,580)		$	4,337		$	(2,552)		$ Notional
Futures			$	—		$	(133)		$	151		$	—		$ Notional
Options			$	54		$	(69)		$	26		$	(44)		Delta
Agricultural commodities
Forwards			50,879,137			(66,649,133)			45,562,983			(70,869,295)			Metric Tons
Swaps			—			(5,499,464)			—			—			Metric Tons
Futures			—			(17,769,326)			—			(12,270,722)			Metric Tons
Options			76,654			(3,098,186)			104,572			(546,978)			Metric Tons
Ocean freight
FFA			—			(10,746)			—			(6,285)			Hire Days
Natural gas
Swaps			1,542,370			—			786,919			—			MMBtus
Futures			11,904,719			—			5,760,755			—			MMBtus
Options			307,093			—			609,579			—			MMBtus
Electricity
Futures			188,846			—			139,435			—			MWh
Energy - other
Swaps			394,543			—			449,326			—			Metric Tons
Futures			—			(133,000)			—			—			Metric Tons
Forwards			60,890			(46,838)			—			—			Metric Tons
Energy - CO2
Futures			730,000			—			503,000			—			Metric Tons
Options			—			—			100,000			—			Metric Tons
Other
Swaps and futures			$	150		$	(200)		$	130		$	(130)		$ Notional

The Effect of Derivative Instruments and Hedge Accounting on the Condensed Consolidated Statements of Income

The tables below summarize the net effect of derivative instruments and hedge accounting on the condensed consolidated statements of income for the three and six months ended June 30, 2026, and 2025.

						Gain (Loss) Recognized in Income on Derivative Instruments
						Three Months Ended June 30,
(US$ in millions)						2026			2025
Income statement classification			Type of derivative
Net sales
Hedge accounting			Foreign currency			$	2		$	—
Cost of goods sold
Economic hedges			Foreign currency			$	109		$	47
			Commodities			826			219
			Other (1)			7			(2)
Total Cost of goods sold						$	942		$	264
Interest expense
Hedge accounting			Interest rate			$	(17)		$	(23)
Economic hedges			Interest rate			1			—
Total Interest expense						$	(16)		$	(23)
Foreign exchange (losses) gains – net
Hedge accounting			Foreign currency			$	(5)		$	—
Economic hedges			Foreign currency			(11)			(8)
Total Foreign exchange (losses) gains – net						$	(16)		$	(8)
Other income (expense)
Economic hedges			Other			$	12		$	—
Other comprehensive income (loss)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period						$	—		$	4
Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period						$	(1)		$	(53)
Amounts released from Accumulated other comprehensive income (loss) during the period
Cash flow hedge of foreign currency risk - loss/(gain)						$	4		$	—

(1) Other includes results from freight, energy, and other derivatives.

						Gain (Loss) Recognized in Income on Derivative Instruments
						Six Months Ended June 30,
(US$ in millions)						2026			2025
Income statement classification			Type of derivative
Net sales
Hedge accounting			Foreign currency			$	3		$	—
Cost of goods sold
Economic hedges			Foreign currency			$	446		$	172
			Commodities			(441)			74
			Other (1)			64			7
Total Cost of goods sold						$	69		$	253
Interest expense
Hedge accounting			Interest rate			$	(31)		$	(45)
Economic hedges			Interest rate			—			—
Total Interest expense						$	(31)		$	(45)
Foreign exchange (losses) gains – net
Hedge accounting			Foreign currency			$	(18)		$	—
Economic hedges			Foreign currency			(154)			37
Total Foreign exchange (losses) gains – net						$	(172)		$	37
Other income (expense)
Economic hedges			Other			$	12		$	—
Other comprehensive income (loss)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period						$	(11)		$	10
Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period						$	(5)		$	(97)
Amounts released from Accumulated other comprehensive income (loss) during the period
Cash flow hedge of foreign currency risk - loss/(gain)						$	16		$	—

(1) Other includes results from freight, energy, and other derivatives.

13. DEBT

The following table summarizes Bunge's short and long-term debt:

(US$ in millions)						June 30, 2026						December 31, 2025
Short-term debt and Current portion of long-term debt:
Revolving credit facilities						$	830					$	600
Commercial paper program						564						300
Other short-term debt						3,194						2,983
Total Short-term debt (1)						4,588						3,883
Current portion of long-term debt						1,200						1,337
Total Short-term debt and Current portion of long-term debt (2)						5,788						5,220
Long-term debt: (3)
Term loan due 2027 - SOFR plus 1.000%						250						250
Term loan due 2028 - SOFR plus 1.200%						250						250
Term loan due 2028 - SOFR plus 1.100%						300						300
Term loan due 2028 - SOFR plus 1.100%						1,000						1,000
2.00% Senior Notes due 2026 (4)						—						575
3.25% Senior Notes due 2026						700						700
4.90% Senior Notes due 2027						442						443
3.75% Senior Notes due 2027						599						599
1.00% Senior Notes due 2028 - Euro						763						779
4.10% Senior Notes due 2028						399						398
4.20% Senior Notes due 2029						795						794
4.55% Senior Notes due 2030						646						645
3.20% Senior Notes due 2031						561						557
2.75% Senior Notes due 2031						994						994
5.25% Senior Notes due 2032						306						307
4.80% Senior Notes due 2033						495						—
4.65% Senior Notes due 2034						792						791
5.15% Senior Notes due 2035						644						643
5.15% Senior Notes due 2036						694						—
Cumulative adjustment to long-term debt from application of hedge accounting						(216)						(128)
Other long-term debt						212						271
Subtotal (5)						10,626						10,168
Less: Current portion of long-term debt						(1,200)						(1,337)
Total Long-term debt (6)						9,426						8,831
Total debt						$	15,214					$	14,051

(1) In the fourth quarter of 2025, Bunge completed the acquisition of ViOil. In connection with the acquisition, Bunge has recognized an obligation of $33 million at June 30, 2026 relating to deferred cash consideration to be settled within one year from the date of the close of the transaction.

(2) Includes secured debt of $768 million and $1,024 million at June 30, 2026, and December 31, 2025, respectively. The balance includes $337 million and $535 million of secured debt collateralized by inventory at June 30, 2026 and December 31, 2025, respectively.

(3) Variable interest rates are as of June 30, 2026.

(4) Upon maturity on April 21, 2026, Bunge repaid the balance outstanding of the 2.00% Senior Notes due 2026.

(5) The fair value (Level 2) of long-term debt, including current portion, is $10,659 million and $10,220 million at June 30, 2026, and December 31, 2025, respectively. The fair value of Bunge's long-term debt is calculated based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge.

(6) Includes secured debt of $151 million and $159 million at June 30, 2026, and December 31, 2025, respectively.

Senior Notes

In March 2026, Bunge Limited Finance Corp ("BLFC"), a wholly owned finance subsidiary of Bunge, completed the sale and issuance of (i) $500 million aggregate principal amount of 4.800% senior notes due 2033, and (ii) $700 million aggregate principal amount of 5.150% senior notes due 2036 (collectively, the "2026 Senior Notes"). The 2026 Senior Notes total an aggregate principal amount of $1.2 billion and are fully and unconditionally guaranteed by Bunge. The offering was made pursuant to a shelf registration statement on Form S-3 (Registration No. 333-282003) filed by the Company and BLFC with the SEC. The net proceeds of the offering were approximately $1.19 billion after deducting underwriting commissions, the original issue discount, and offering fees and expenses payable by Bunge.

14. RELATED PARTY TRANSACTIONS

Bunge purchases agricultural commodity products from certain of its unconsolidated investees and other related parties. Such related party purchases comprised approximately 9% or less of total Cost of goods sold for the three and six months ended June 30, 2026, and 2025. Bunge also sells agricultural commodity products to certain of its unconsolidated investees and other related parties. Such related party sales comprised approximately 3% or less of total Net sales for the three and six months ended June 30, 2026, and 2025.

In addition, Bunge receives services from and provides services to its unconsolidated investees, including tolling, port handling, administrative support, and other services. For the three and six months ended June 30, 2026, and 2025, such services were not material to the Company’s consolidated results.

At June 30, 2026, and at December 31, 2025, receivables related to the above related party transactions comprised approximately 5% or less of total Trade accounts receivable. At June 30, 2026, and December 31, 2025, payables related to the above related party transactions comprised approximately 2% or less of total Trade accounts payable.

Further, as referenced in Note 6 - Other Current Assets and Note 7 - Other Non-Current Assets, Bunge provides certain advance payments for future delivery of specified quantities of agricultural commodities and advances to its unconsolidated investees. At June 30, 2026, and at December 31, 2025, advances to unconsolidated investees comprised approximately 4% or less of total Other current assets and 5% or less of total Other non-current assets.

Bunge believes all transaction values to be similar to those that would be conducted with third parties at arm's-length.

15. COMMITMENTS AND CONTINGENCIES

Bunge is party to claims and lawsuits, primarily from indemnities provided to third parties and labor claims in South America, arising in the normal course of business. Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation, and other litigation, claims, government investigations, and legal proceedings. The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties. Bunge records liabilities related to legal matters when the exposure item becomes probable and can be reasonably estimated. Bunge management does not expect these matters to have a material adverse effect on Bunge’s financial condition, results of operations, or liquidity. However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period in which the uncertainties are resolved should the liability substantially exceed the amount of provisions included in the condensed consolidated balance sheets. Information regarding the claims appears in Bunge’s Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 19, 2026. Included in Other non-current liabilities as of June 30, 2026, and December 31, 2025, are the following amounts related to these matters:

(US$ in millions)			June 30, 2026						December 31, 2025
Non-income tax claims			$	88					$	86
Labor claims			41						35
Civil and other claims			291						276
Asset retirement obligations			110						110
Total			$	530					$	507

Brazil Indirect Taxes - non-income tax claims - These tax claims relate to claims against Bunge’s Brazilian subsidiaries, primarily value-added tax claims (ICMS, ISS, IPI and PIS/COFINS) plus applicable interest and penalties on the outstanding amount.

As of June 30, 2026, the Brazilian federal and state authorities have concluded examinations of the ICMS and PIS/COFINS tax returns and have issued outstanding claims. The Company continues to evaluate the merits of each of these claims and will recognize them if and when loss is considered probable. The outstanding claims comprise the following:

(US$ in millions)			Years Examined			June 30, 2026			December 31, 2025
ICMS			1990 to Present			$	163		$	155
PIS/COFINS			2002 to Present			$	598		$	490

Labor claims — The labor claims are principally against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits.

Civil and other claims — The civil and other claims relate to various disputes with third parties, including suppliers, customers, and government entities.

Guarantees — Bunge has issued or was a party to the following guarantees at June 30, 2026:

(US$ in millions)			Recorded Liability						Maximum Potential Future Payments
Unconsolidated affiliates guarantee (1)			$	15					$	206
Residual value guarantee (2)			—						318
Total			$	15					$	524

(1) Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2041. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. In addition, certain Bunge subsidiaries have guaranteed the obligations of certain of their unconsolidated affiliates and in connection therewith have secured their guarantee obligations through a pledge to the financial institutions of certain of their unconsolidated affiliates' shares plus loans receivable from the unconsolidated affiliates in the event that the guaranteed obligations are enforced. Based on the amounts drawn under guaranteed debt facilities at June 30, 2026, Bunge's potential liability was $180 million, and it has recorded $15 million of obligations related to these guarantees within Other current liabilities and Other non-current liabilities.

(2) Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges, and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term, if certain terms are elected by Bunge. These leases expire at various dates from 2027 through 2031. At June 30, 2026, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations.

Bunge Global SA has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. ("BNA"), an indirect wholly-owned subsidiary, which guarantees all amounts due and owing by BNA to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.

Indemnities—Over the years, Bunge has entered into various agreements to divest certain business activities which included indemnification provisions primarily related to legal claims. These indemnities have varying terms, with some expiring in 10 years or less and others having no stated expiration date. At both June 30, 2026 and December 31, 2025, Bunge recognized a $125 million obligation in Other non-current liabilities related to these indemnities and had maximum potential future payments of $1.6 billion.

16. OTHER NON-CURRENT LIABILITIES

Other non-current liabilities consist of the following:

(US$ in millions)			June 30, 2026						December 31, 2025
Labor, legal, and other provisions			$	573					$	551
Pension, postretirement, and post-employment obligations			180						180
Uncertain income tax positions (1)			88						77
Unrealized losses on derivative contracts, at fair value (2)			225						120
Other			119						135
Total			$	1,185					$	1,063

(1)See Note 9 - Income Taxes.

(2)See Note 11 - Fair Value Measurements.

17. EQUITY

Share repurchase program — During the three and six months ended June 30, 2026, Bunge repurchased 1,966,107 registered shares for $249 million under an existing share repurchase program, which was completed in the quarter.

On March 9, 2026, Bunge Global SA's Board of Directors approved a new program for the repurchase of up to $3.0 billion of Bunge's issued and outstanding registered shares. Total remaining purchase authorizations were $3.0 billion as of June 30, 2026. The program has an indefinite term.

Dividends on registered shares — We paid cash dividends to shareholders as follows:

			Three Months Ended June 30,												Six Months Ended June 30,
			2026						2025						2026						2025
Dividends paid per share			$	0.72					$	0.70					$	1.42					$	1.38

Dividend distributions are at the discretion of the Board of Directors and the approval of shareholders at a general meeting in accordance with Swiss law. On May 20, 2026, shareholders of Bunge Global SA approved a cash dividend distribution in the amount of $2.88 per share, payable in four equal quarterly installments of $0.72 per share beginning in the second quarter of fiscal year 2026 and ending in the first quarter of fiscal year 2027.

Upon approval of a dividend, the obligation is reflected in Other current liabilities with a corresponding reduction in Retained earnings in the condensed consolidated balance sheet. At June 30, 2026, and December 31, 2025, the unpaid portion of the dividends accrued in Other current liabilities on the condensed consolidated balance sheets totaled $415 million and $135 million, respectively, see Note 10 - Other Current Liabilities.

Accumulated other comprehensive income (loss) attributable to Bunge — The following table summarizes the balances of related after-tax components of Accumulated other comprehensive income (loss) attributable to Bunge:

(US$ in millions)			Foreign Exchange Translation Adjustment			Deferred Gains (Losses) on Hedging Activities			Pension and Other Postretirement Liability Adjustments						Accumulated Other Comprehensive Income (Loss)
Balance, April 1, 2026			$	(5,553)		$	(421)		$	(43)					$	(6,017)
Other comprehensive income (loss) before reclassifications			—			(1)			—						(1)
Amount reclassified from accumulated other comprehensive income (loss)			—			4			—						4
Balance, June 30, 2026			$	(5,553)		$	(418)		$	(43)					$	(6,014)

(US$ in millions)			Foreign Exchange Translation Adjustment			Deferred Gains (Losses) on Hedging Activities			Pension and Other Postretirement Liability Adjustments									Accumulated Other Comprehensive Income (Loss)
Balance, April 1, 2025			$	(5,952)		$	(344)		$	(140)								$	(6,436)
Other comprehensive income (loss) before reclassifications			357			(49)			—									308
Amount reclassified from accumulated other comprehensive income (loss)			1			—			4									5
Balance, June 30, 2025			$	(5,594)		$	(393)		$	(136)								$	(6,123)

(US$ in millions)			Foreign Exchange Translation Adjustment			Deferred Gains (Losses) on Hedging Activities			Pension and Other Postretirement Liability Adjustments						Accumulated Other Comprehensive Income (Loss)
Balance, January 1, 2026			$	(5,623)		$	(418)		$	(43)					$	(6,084)
Other comprehensive income (loss) before reclassifications			70			(16)			—						54
Amount reclassified from accumulated other comprehensive income (loss)			—			16			—						16
Balance, June 30, 2026			$	(5,553)		$	(418)		$	(43)					$	(6,014)

(US$ in millions)			Foreign Exchange Translation Adjustment			Deferred Gains (Losses) on Hedging Activities			Pension and Other Postretirement Liability Adjustments									Accumulated Other Comprehensive Income (Loss)
Balance, January 1, 2025			$	(6,253)		$	(309)		$	(140)								$	(6,702)
Other comprehensive income (loss) before reclassifications			610			(87)			—									523
Amount reclassified from accumulated other comprehensive income (loss)			1			—			4									5
Sale of redeemable noncontrolling interest			48			3			—									51
Balance, June 30, 2025			$	(5,594)		$	(393)		$	(136)								$	(6,123)

18. EARNINGS PER SHARE

Share information provided below, including references to Net income (loss) attributable to Bunge shareholders, Weighted-average number of shares outstanding, and Earnings per share have been calculated based on Bunge’s registered shares.

The following table sets forth the computation of basic and diluted earnings per share:

			Three Months Ended June 30,												Six Months Ended June 30,
(US$ in millions, except for share data)			2026						2025						2026						2025
Net income (loss) attributable to Bunge shareholders			$	678					$	354					$	746					$	555
Weighted-average number of shares outstanding:
Basic			193,629,135						134,493,236						193,690,779						134,278,611
Effect of dilutive shares:
—stock options and awards (1)			1,712,607						1,106,007						1,845,397						1,218,967
Diluted			195,341,742						135,599,243						195,536,176						135,497,578
Earnings per share:
Net income (loss) attributable to Bunge shareholders—basic			$	3.50					$	2.63					$	3.85					$	4.14
Net income (loss) attributable to Bunge shareholders—diluted			$	3.47					$	2.61					$	3.81					$	4.10

(1) The weighted-average shares outstanding-diluted exclude less than 1 million outstanding stock options or contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for each of the three and six months ended June 30, 2026, and 2025, respectively.

19. SEGMENT INFORMATION

Effective in the third quarter of 2025, the Company changed its reportable segments to align with its new value chain operational structure as a result of the completion of the Acquisition of Viterra. Further, during the first quarter of 2026, the Other Oilseeds Processing and Refining segment was renamed to Tropical Oils and Specialty Ingredients. The segment name change had no impact on the composition of the Company’s existing four reportable segments, nor the Company’s previously reported segment results and consolidated financial statements. See Note 1 - Basis of Presentation, Principles of Consolidation, and Significant Accounting Policies.

Following the changes, the Company's operations are organized, managed, and classified into four reportable segments - Soybean Processing and Refining, Softseed Processing and Refining, Tropical Oils and Specialty Ingredients, and Grain Merchandising and Milling, organized based upon their similar economic characteristics, products and services offered, production processes, types and classes of customer, and distribution methods. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other.

The Soybean Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybeans and soybean related products, as well as biodiesel and fertilizer production and distribution. The Softseed Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of softseeds (canola/rapeseed and sunflower seed) and softseed related products, as well as biodiesel production and distribution. The Tropical Oils and Specialty Ingredients segment is a globally integrated business principally involved in products of a specialty nature, including the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of these related products. The Grain Merchandising and Milling segment involves the purchase, storage, transportation, distribution, and marketing of certain commodities primarily consisting of corn, wheat, barley, cotton, pulses, and sugar; activities also include the milling of wheat and sugar; and related services including ocean freight and financial services.

Corporate and Other includes salaries and overhead for corporate functions, including acquisition and integration costs related to the Viterra Acquisition, that are not allocated to the Company’s individual reporting segments because the operating performance of each reporting segment is evaluated by the Company’s chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company’s captive insurance activities, accounts receivable securitization activities, and certain income tax assets and liabilities.

Transfers between the segments are valued at market. The segment revenues generated from these transfers are shown in the following table as "Inter-segment revenues."

			Three Months Ended June 30, 2026
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Eliminations			Total Reportable Segments			Corporate and Other			Total Bunge Consolidated
Net sales to external customers			$	12,071		$	4,095		$	1,259		$	6,614		$	—		$	24,039		$	2		$	24,041
Inter–segment revenues			241			359			94			800			(1,494)									—
Raw materials cost			(10,492)			(3,531)			(1,075)			(6,060)			—						5			(21,153)
Industrial expenses- fixed			(279)			(147)			(90)			(160)			—						(1)			(677)
Industrial expenses- variable			(159)			(72)			(30)			(28)			—						—			(289)
Depreciation			(87)			(45)			(26)			(77)			—						(6)			(241)
Selling, general and administrative expenses			(164)			(63)			(60)			(129)			—						(190)			(606)
Other segment items (1)			(86)			36			(2)			13									24			(15)
EBIT			804			273			(24)			173			—			1,226			(166)			1,060
Depreciation, depletion and amortization			(88)			(44)			(34)			(84)			—			(250)			(6)			(256)
Income (loss) from affiliates			—			(2)			—			11						9			—			9
Total assets			19,744			7,595			4,164			12,953			—			44,456			2,326			46,782
Capital expenditures			217			41			122			57			—			437			6			443

			Three Months Ended June 30, 2025
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Eliminations			Total Reportable Segments			Corporate and Other			Total Bunge Consolidated
Net sales to external customers			$	7,750		$	1,531		$	1,152		$	2,334		$	—		$	12,767		$	2		$	12,769
Inter–segment revenues			133			295			81			329			(838)						—			—
Raw materials cost			(6,804)			(1,349)			(979)			(2,158)			—						(2)			(11,292)
Industrial expenses- fixed			(213)			(77)			(75)			(67)			—						2			(430)
Industrial expenses- variable			(123)			(39)			(25)			(14)			—						—			(201)
Depreciation			(52)			(21)			(17)			(12)			—						(6)			(108)
Selling, general and administrative expenses			(113)			(38)			(61)			(62)			—						(144)			(418)
Other segment items (1)			15			12			(5)			166			—						30			218
EBIT			460			19			(10)			187			—			656			(118)			538
Depreciation, depletion and amortization			(52)			(21)			(25)			(12)			—			(110)			(6)			(116)
Income (loss) from affiliates			2			(1)			—			2			—			3			—			3
Total assets			13,347			2,488			3,417			4,102			—			23,354			7,800			31,154
Capital expenditures			193			14			161			33			—			401			5			406

			Six Months Ended June 30, 2026
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Eliminations			Total Reportable Segments			Corporate and Other			Total Bunge Consolidated
Net sales to external customers			$	21,623		$	7,999		$	2,487		$	13,791		$	—		$	45,900		$	2		$	45,902
Inter–segment revenues			423			792			192			1,326			(2,733)									—
Raw materials cost			(19,154)			(7,046)			(1,980)			(12,967)			—						9			(41,138)
Industrial expenses- fixed			(545)			(280)			(172)			(296)			—						1			(1,292)
Industrial expenses- variable			(301)			(150)			(57)			(52)			—						—			(560)
Depreciation			(171)			(87)			(52)			(142)			—						(13)			(465)
Selling, general and administrative expenses			(307)			(124)			(121)			(256)			—						(329)			(1,137)
Other segment items (1)			(132)			37			(19)			19			—						29			(66)
EBIT			1,013			349			86			97			—			1,545			(301)			1,244
Depreciation, depletion and amortization			(172)			(87)			(68)			(154)			—			(481)			(13)			(494)
Income (loss) from affiliates			5			(2)			—			11			—			14			(2)			12
Total assets			19,744			7,595			4,164			12,953			—			44,456			2,326			46,782
Capital expenditures			370			65			236			99			—			770			9			779

			Six Months Ended June 30, 2025
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Eliminations			Total Reportable Segments			Corporate and Other			Total Bunge Consolidated
Net sales to external customers			$	14,411		$	3,046		$	2,235		$	4,718		$	—		$	24,410		$	2		$	24,412
Inter–segment revenues			286			656			168			621			(1,731)						—			—
Raw materials cost			(12,772)			(2,630)			(1,878)			(4,376)			—						6			(21,650)
Industrial expenses- fixed			(413)			(141)			(142)			(129)			—						9			(816)
Industrial expenses- variable			(232)			(81)			(52)			(27)			—						—			(392)
Depreciation			(101)			(40)			(39)			(28)			—						(11)			(219)
Selling, general and administrative expenses			(222)			(73)			(119)			(121)			—						(263)			(798)
Other segment items (1)			60			20			(10)			196			—						63			329
EBIT			731			101			(5)			233			—			1,060			(194)			866
																								—
Depreciation, depletion and amortization			(101)			(40)			(55)			(29)			—			(225)			(11)			(236)
Income (loss) from affiliates			13			(6)			—			1			—			8			—			8
Total assets			13,347			2,488			3,417			4,102			—			23,354			7,800			31,154
Capital expenditures			343			25			285			51			—			704			12			716

(1) Other segment items for each reportable segment includes Foreign exchange gains (losses) – net, Other income (expense) – net, Income (loss) from affiliates, and EBIT – Noncontrolling interests, which includes Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests adjusted for noncontrolling interests' share of interest and taxes.

A reconciliation of Total reportable segment EBIT to Income (loss) before income tax follows:

			Three Months Ended June 30,												Six Months Ended June 30,
(US$ in millions)			2026						2025						2026						2025
Total reportable segment EBIT			$	1,226					$	656					$	1,545					$	1,060
Corporate and Other EBIT			(166)						(118)						(301)						(194)
EBIT - Noncontrolling interests			37						16						50						17
Interest income			43						46						88						105
Interest expense			(197)						(106)						(378)						(210)
Income (loss) before income tax			$	943					$	494					$	1,004					$	778

The Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging ("ASC 815") and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts with Customers ("ASC 606"). The following tables provide a disaggregation of Net sales to external customers between sales from commodity contracts (ASC 815) and sales from contracts with customers (ASC 606):

			Three Months Ended June 30, 2026
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Corporate and Other			Total
Sales from commodity contracts (ASC 815)			$	10,019		$	2,900		$	79		$	6,113		$	—		$	19,111
Sales from contracts with customers (ASC 606)			2,052			1,195			1,180			501			2			4,930
Net sales to external customers			$	12,071		$	4,095		$	1,259		$	6,614		$	2		$	24,041

			Three Months Ended June 30, 2025
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Corporate and Other			Total
Sales from commodity contracts (ASC 815)			$	6,172		$	686		$	60		$	1,830		$	—		$	8,748
Sales from contracts with customers (ASC 606)			1,578			845			1,092			504			2			4,021
Net sales to external customers			$	7,750		$	1,531		$	1,152		$	2,334		$	2		$	12,769

			Six Months Ended June 30, 2026
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Corporate and Other			Total
Sales from commodity contracts (ASC 815)			$	17,766		$	5,727		$	102		$	12,717		$	—		$	36,312
Sales from contracts with customers (ASC 606)			3,857			2,272			2,385			1,074			2			9,590
Net sales to external customers			$	21,623		$	7,999		$	2,487		$	13,791		$	2		$	45,902

			Six Months Ended June 30, 2025
(US$ in millions)			Soybean Processing and Refining			Softseed Processing and Refining			Tropical Oils and Specialty Ingredients			Grain Merchandising and Milling			Corporate and Other			Total
Sales from commodity contracts (ASC 815)			$	11,531		$	1,400		$	70		$	3,727		$	—		$	16,728
Sales from contracts with customers (ASC 606)			2,880			1,646			2,165			991			2			7,684
Net sales to external customers			$	14,411		$	3,046		$	2,235		$	4,718		$	2		$	24,412

Cautionary Statement Regarding Forward Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward looking statements to encourage companies to provide prospective information to investors. This Form 10-Q includes forward looking statements that reflect our current expectations and projections about our future results, performance, prospects and opportunities. Forward looking statements include all statements that are not historical in nature. We have tried to identify these forward looking statements by using words including "may," "will," "should," "could," "expect," "anticipate," "believe," "plan," "intend," "estimate," "continue" and similar expressions. These forward looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. The following factors, among others, could cause actual results to differ from these forward looking statements:

• the impact on our employees, operations, and facilities from the war in Ukraine and the resulting economic and other sanctions imposed on Russia, including the impact on us resulting from the continuation and/or escalation of the war and sanctions against Russia;

• the effect of weather conditions and the impact of crop and animal disease on our business;

• the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions;

• changes in government policies and laws affecting our business, including agricultural, trade, tariff and foreign investment policies, financial markets regulation and environmental, tax and biofuels regulation;

• the impact of seasonality;

• the outcome of pending regulatory and legal proceedings;

• our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances, including without limitation Bunge’s business combination with Viterra Limited;

• the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries;

• the effectiveness of our capital allocation plans, funding needs and financing sources;

• the effectiveness of our risk management strategies;

• operational risks, including industrial accidents, natural disasters, pandemics or epidemics, wars and cybersecurity incidents;

• changes in foreign exchange policy or rates;

• the impact of our dependence on third parties;

• our ability to attract and retain executive management and key personnel; and

• other factors affecting our business generally.

The forward looking statements included in this report are made only as of the date of this report, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.

You should refer to “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 19, 2026 and “Part II — Item 1A. Risk Factors” in this Quarterly Report on Form 10-Q for a more detailed discussion of these factors, as well as other risks and uncertainties set forth from time to time in reports subsequently filed with the SEC.